Capital Investment Advisory Services LLC Reduces Holdings in Invesco Pharmaceuticals ETF (NYSEARCA:PJP)

Capital Investment Advisory Services LLC decreased its position in shares of Invesco Pharmaceuticals ETF (NYSEARCA:PJP) by 24.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,308 shares of the company’s stock after selling 1,763 shares during the quarter. Capital Investment Advisory Services LLC owned 0.14% of Invesco Pharmaceuticals ETF worth $404,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Horizon Bancorp Inc. IN purchased a new stake in shares of Invesco Pharmaceuticals ETF in the third quarter valued at approximately $59,000. Kraft Davis & Associates LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the fourth quarter worth approximately $277,000. Modera Wealth Management LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the third quarter worth approximately $538,000. Commonwealth Retirement Investments LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the fourth quarter worth approximately $1,557,000. Finally, Cambridge Investment Research Advisors Inc. increased its position in shares of Invesco Pharmaceuticals ETF by 206.0% during the third quarter. Cambridge Investment Research Advisors Inc. now owns 41,273 shares of the company’s stock worth $2,987,000 after purchasing an additional 27,786 shares in the last quarter.

Invesco Pharmaceuticals ETF Stock Performance

Shares of PJP opened at $76.40 on Wednesday. Invesco Pharmaceuticals ETF has a one year low of $67.75 and a one year high of $80.65. The stock has a market capitalization of $268.17 million, a price-to-earnings ratio of 20.52 and a beta of 0.64. The stock has a 50 day moving average price of $77.94 and a 200 day moving average price of $74.94.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.